Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (581-590 of 842) with videos related to

Pageof 85
Sort By:
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.
The Canadian Journal of Cardiology|August 18, 2014
Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3)Justin A Ezekowitz, Robert C Welsh, Courtney Gubbels, et al.
JACC. Heart Failure|December 21, 2023
Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection FractionMichael A Fuery, Eric S Leifer, Marc D Samsky, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 13, 2019
Quantification of lung water in heart failure using cardiovascular magnetic resonance imagingRichard B Thompson, Kelvin Chow, Joseph J Pagano, et al.
CJC Open|February 24, 2022
Prevalence of Cardiovascular Disease in a Population-Based Cohort of High-Cost Healthcare Services UsersPadma Kaul, Nathan Klassen, Douglas C Dover, et al.
Cardiovascular Diabetology|February 2, 2024
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trialJames L Januzzi, Stefano Del Prato, Julio Rosenstock, et al.
JAMA Cardiology|November 13, 2020
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA TrialCarolyn S P Lam, Anna Giczewska, Karen Sliwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated CardiotoxicityEdith Pituskin, John R Mackey, Sheri Koshman, et al.
Open Heart|March 20, 2021
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areasTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.
Journal of Cardiac Failure|August 25, 2024
Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction TrialCynthia M Westerhout, Sarah Rathwell, Kevin J Anstrom, et al.
Pageof 85

Showing results (581-590 of 842) with videos related to

Sort By:
Pageof 85
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.
The Canadian Journal of Cardiology|August 18, 2014
Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 (PROACT-3)Justin A Ezekowitz, Robert C Welsh, Courtney Gubbels, et al.
JACC. Heart Failure|December 21, 2023
Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection FractionMichael A Fuery, Eric S Leifer, Marc D Samsky, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|September 13, 2019
Quantification of lung water in heart failure using cardiovascular magnetic resonance imagingRichard B Thompson, Kelvin Chow, Joseph J Pagano, et al.
CJC Open|February 24, 2022
Prevalence of Cardiovascular Disease in a Population-Based Cohort of High-Cost Healthcare Services UsersPadma Kaul, Nathan Klassen, Douglas C Dover, et al.
Cardiovascular Diabetology|February 2, 2024
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trialJames L Januzzi, Stefano Del Prato, Julio Rosenstock, et al.
JAMA Cardiology|November 13, 2020
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA TrialCarolyn S P Lam, Anna Giczewska, Karen Sliwa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated CardiotoxicityEdith Pituskin, John R Mackey, Sheri Koshman, et al.
Open Heart|March 20, 2021
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areasTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.
Journal of Cardiac Failure|August 25, 2024
Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction TrialCynthia M Westerhout, Sarah Rathwell, Kevin J Anstrom, et al.
Pageof 85